MedLife S.A.

MedLife S.A.

About MedLife S.A.

MedLife is the largest private healthcare provider in Romania. The company operates the widest network of clinics, one of the large networks of medical laboratories, general and specialised hospitals and it has the largest client database for Healthcare Prevention Packages in the country. In addition, from the standpoint of sales, it is one of the largest private healthcare companies in Central and Eastern Europe, according to the public information available to MedLife Group.

The shares issued by MedLife SA are traded on the spot regulated market managed by the Bucharest Stock Exchange, Premium Category, with the “M” trading symbol.

President: MARCU MIHAIL

Shareholder structure

Shareholder Shares Percent
CRISTESCU MIHAELA GABRIELA 3,013,800 15.00%
MARCU NICOLAE 3,013,800 15.00%
MARCU MIHAIL 4,219,320 21.00%
alti actionari / others 9,845,080 49.00%
Total 20,092,000 100%

Info provided by: DEPOZITARUL CENTRAL Date: -

Market statistics

  • Today
  • 1 Week
  • 1 Month
  • 6 Month
  • 1 Year
Volume

Preventive testing. New RT PCR laboratory

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:"Segoe UI"; panose-1:2 11 5 2 4 2 4 2 2 3;} @font-face {font-family:Tahoma; panose-1:2 11 ...

Report according art. 82 Law 24/2017 - February 2020

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:PMingLiU; panose-1:2 2 5 0 0 0 0 0 0 0;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:"Calibri Light"; panose-1:2 ...

Launching RT PCR Laboratory; update on the COVID-19 positive case

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:"Segoe UI"; panose-1:2 11 5 2 4 2 4 2 2 3;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNorma ...

Current report - MedLife management team measures following coronavirus outbreak

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:PMingLiU; panose-1:2 2 5 0 0 0 0 0 0 0;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:"Calibri Light"; panose-1:2 15 3 2 ...

Announcement regarding a patient diagnosed with COVID19- Grivita Maternity

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {margin-top:0in; margin-right:0in; margin-bottom:8.0pt; margin-left:0in; line-height:106%; font-size:11.0pt; fon ...

MedLife launches the online medical advice service via video conferencing

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:"Segoe UI"; panose-1:2 11 5 2 4 2 4 2 2 3;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNorma ...

Notice of O&EGSM - April 23, 2020

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:PMingLiU; panose-1:2 2 5 0 0 0 0 0 0 0;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:"Calibri Light"; panose-1:2 ...

Actions implemented to prevent and limit the spread of COVID-19

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:"Segoe UI"; panose-1:2 11 5 2 4 2 4 2 2 3;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNorma ...

Erratum - Disclosure of holdings over 10% of the total voting rights

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:PMingLiU; panose-1:2 2 5 0 0 0 0 0 0 0;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:"Calibri Light"; panose-1:2 ...

Disclosure of holdings over 10% of the total voting rights

/* Font Definitions */ @font-face {font-family:Wingdings; panose-1:5 0 0 0 0 0 0 0 0 0;} @font-face {font-family:PMingLiU; panose-1:2 2 5 0 0 0 0 0 0 0;} @font-face {font-family:Mangal; panose-1:2 4 5 3 5 2 3 3 2 2;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:"Calibri Light"; panose-1:2 ...

Preliminary financial results 2019

REPORT Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and marke ...

Communique Q3 2019 financial results

/* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} @font-face {font-family:"Segoe UI"; ...

Q3 2019 Report

REPORT Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and marke ...

Half-year financial results H1 2019

To: BUCHAREST STOCK EXCHANGE        FINANCIAL SUPERVISORY AUTHORITY     REPORT Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and mar ...

Communique Q1 2019 financial results

  MedLife ended Q1 with an increase of 27.6% compared to prior year and announces the continuation of the acquisition program in Romania and the region   May 15, 2019, Bucharest: MedLife, ...

2019 Q1 Report

  To: BUCHAREST STOCK EXCHANGE        FINANCIAL SUPERVISORY AUTHORITY     REPORT Report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial in ...

2018 Annual report

In accordance with Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations   Report Date: 23 Ap ...

Preliminary financial results 2018 - Amendment to Romanian version of the Report

   

Preliminary financial results 2018

  To: BUCHAREST STOCK EXCHANGE        FINANCIAL SUPERVISORY AUTHORITY     REPORT Current report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of finan ...

Announcement Financial Results Q3 2018

MedLife announces Pro-forma Sales of 606.16 m RON for the first 9 months of this year, up by 32% as compared to 2017 There are indicators that by the end of 2019 Medlife will become the first medi ...

Financial indicators

Year Financial statements Key financials Ministry of Finance format (excerpt)*
2016 Financial preliminary results 2016 Download -
2016 H1 2016 Download -
2016 Q3 2016 Download -
2015 Annual Report 2015 Download -

ANALYST ESTIMATES

ANALYST REPORT February 15, 2017

MedLife: revenues beat expectations, 4Q EBITDA marred by one-offs

M - MedLife S.A.

February 15, 2017 - One-off IPO and M&A-related costs were reflected negatively in MedLife’s reported 4Q16 results, depressing the closely watched EBITDA margin; however, excluding these costs, on an adjusted or pro forma basis, EBITDA was basically in line with our forecast of RON 19.8m. Strong top-line growth – 36% yoy in 4Q and 29% for FY16 – was, however, a positive surprise and suggests to us that profitability can improve throughout 2017E as the impact of higher 4Q15/1H16 employee costs works through the figures, and synergies on recent acquisitions flow to the bottom line (we note that management is also executing plans so these synergies are shared more fairly with equity holders). Management admits that extracting these economies of scale takes time and, while achieving pre-2016 profitability is a key factor for investors, the 4Q results indicate that targeted earnings can be achieved in the meantime through better-than expected top-line growth Achieving the benefits of scale, together with consolidating the Romanian healthcare market, are the key points of our investments thesis for the company. To date, we can see MedLife working towards these goals, and we remain BUYers of the stock.

ANALYST REPORT February 07, 2017

MedLife. A healthy play on the Romanian consumer

M - MedLife S.A.

February 07, 2017 - MedLife offers a rare opportunity to invest in Romanian consumer demand growth and market consolidation. The Romanian private healthcare market should grow by a 17% CAGR through to 2018E, on our estimates, supported by rising disposable income, low per capita spending by regional standards, and a pervasive mistrust of the public healthcare system. MedLife is an active market consolidator and sees untapped potential in second- and third-tier cities, as well as niche areas, such as dentistry.

ANALYST ESTIMATES

Investor Information

Company Presentation

Previous
Next

IR Presentation

  • Date
  • Documents
Previous
Next